MLAB vs. SENS, ZYME, SVRA, AUNA, SLN, VREX, DH, QTRX, LYEL, and EYPT
Should you be buying Mesa Laboratories stock or one of its competitors? The main competitors of Mesa Laboratories include Senseonics (SENS), Zymeworks (ZYME), Savara (SVRA), Auna (AUNA), Silence Therapeutics (SLN), Varex Imaging (VREX), Definitive Healthcare (DH), Quanterix (QTRX), Lyell Immunopharma (LYEL), and EyePoint Pharmaceuticals (EYPT). These companies are all part of the "medical" sector.
Senseonics (NYSE:SENS) and Mesa Laboratories (NASDAQ:MLAB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends, community ranking and institutional ownership.
Mesa Laboratories has a net margin of 0.45% compared to Mesa Laboratories' net margin of -346.38%. Senseonics' return on equity of 7.41% beat Mesa Laboratories' return on equity.
Senseonics presently has a consensus price target of $1.25, suggesting a potential upside of 167.55%. Mesa Laboratories has a consensus price target of $130.00, suggesting a potential upside of 6.24%. Given Mesa Laboratories' higher possible upside, analysts plainly believe Senseonics is more favorable than Mesa Laboratories.
Mesa Laboratories received 216 more outperform votes than Senseonics when rated by MarketBeat users. Likewise, 63.82% of users gave Mesa Laboratories an outperform vote while only 16.67% of users gave Senseonics an outperform vote.
Senseonics has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, Mesa Laboratories has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500.
Mesa Laboratories has higher revenue and earnings than Senseonics. Senseonics is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.
In the previous week, Senseonics had 9 more articles in the media than Mesa Laboratories. MarketBeat recorded 10 mentions for Senseonics and 1 mentions for Mesa Laboratories. Mesa Laboratories' average media sentiment score of 0.40 beat Senseonics' score of 0.00 indicating that Senseonics is being referred to more favorably in the media.
12.4% of Senseonics shares are owned by institutional investors. Comparatively, 90.6% of Mesa Laboratories shares are owned by institutional investors. 3.9% of Senseonics shares are owned by insiders. Comparatively, 5.2% of Mesa Laboratories shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
Mesa Laboratories beats Senseonics on 12 of the 17 factors compared between the two stocks.
Get Mesa Laboratories News Delivered to You Automatically
Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MLAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mesa Laboratories Competitors List
Related Companies and Tools
